Oriental Fortune Joins CICC in Biologics Therapy Play
03 Oct 2025
US$ 20.00
Oriental Fortune Capital was party to the near Rmb600 m (US$84.3 m) series C2 funding round of TJ Biopharma (Hangzhou)...
Related Publications
Hahn & Co (Hahn) is to dispose of its entire stakes in K Car Co Ltd (K Car) and the latter’s unlisted sister company ......
Glow Capital Partners has acquired a majority stake in Menzies Group Pty Ltd (Menzies) for an undisclosed ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.